- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06862466
Impact of an Intervention Education Program on the Knowledge, Attitudes, and Practices of Dietitians
Impact Of An Intervention Education Program On The Knowledge, Attitudes, And Practices Of Dietitians Working With Chronic Kidney Disease Patients In Public Hospitals Of Saudi Arabia
Study Overview
Detailed Description
A cluster randomized controlled trial will be conducted to evaluate the effectiveness of the intervention on the level of knowledge, attitude, and practice in renal nutrition competencies among the dietitians. A total of 100 participants (50 participants for each group) will be select using simple random sampling.
The education intervention program will be developed based on the literature review of the guidelines for the nutritional management of CKD by looking into all evidence-based practice guidelines of renal medical nutrition therapy. The education intervention will include five weeks of in-person education sessions. The education intervention program will cover five lessons including nutrition assessment for CKD, malnutrition, macro- and micronutrients deficiencies in CKD, nutrition intervention and counselling skills. The education program will be delivered through lectures, workshops, brainstorming and case studies using materials such as PowerPoints, videos, cards, posters, booklets and activities. The program will be offered online via Zoom software, and the learners will have the materials to review at home. The program will be provided in close collaboration between the researcher and the hospital's nutrition department.
Data will be collected from four selected public hospitals in Jazan city, Saudi Arabia, by direct interview of the dietitians in the hospitals to determine the competency assessment on knowledge, attitude, and practice of renal nutrition. All respondents in the hospitals will be evaluated before the start of the program (baseline evaluation), after the final intervention session (post-intervention evaluation), and three months after intervention (three-month follow-up after intervention). Data will be analyzed by using the software Statistical Package for Social Sciences (SPSS) version 26.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selangor
-
Serdang, Selangor, Malaysia, 43300
- Recruiting
- Universiti Putra Malaysia
-
Contact:
- Zulfitri 'Azuan Mat Daud, PhD
- Phone Number: +603-9769 12444
- Email: zulfitri@upm.edu.my
-
Contact:
- Shatha Alattar, Master
- Phone Number: +966555604580
- Email: GS66695@upm.edu.my
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Dietitians who worked with chronic kidney disease patients.
- Dietitians who registered in Saudi Commission for Health Specialties.
- Completed at least one-year experience in their job.
- Dietitians who agree to participate in the study.
- Dietitians who are available at the time of data collection.
Exclusion Criteria:
- Medical doctor dietitians.
- Internship and student.
- Dietitians under one-year experience.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Education intervention program
The intervention group will have an education intervention program which will cover five lessons including nutrition assessment for CKD, malnutrition, macro- and micronutrients deficiencies in CKD, nutrition intervention and counselling skills.
The education program will be delivered through lectures, workshops, brainstorming and case studies using materials such as PowerPoints, videos, cards, posters, booklets and activities.
The program will be offered online via Zoom software, and the learners will have the materials to review at home.
The program will be provided in close collaboration between the researcher and the hospital's nutrition department.
|
Knowledge, Attitude, and Practice Questionnaire (KAPQ) Regarding Renal Nutrition will be used to collect the data at baseline, after the intervention, and three months follow-up, which is adjusted for clustering.
|
|
No Intervention: No Intervention: Control group
The control group will not have any intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved in Knowledge Regarding Renal Nutrition
Time Frame: Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
A structured assessment designed to evaluate knowledge and perception of nutrition care including dietary guidelines, nutrient functions, and health benefits will be explored.
The assessment consists of 25 questions, each aimed at gauging the respondents' understanding of various aspects of nutrition.
Each question will have multiple-choice answers, with one correct answer and several distractors.
The best answer will be coded as "1" and the wrong answer as "0".
There will be a maximum score of 25 and a minimum of 0.
|
Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
|
Improved in Attitude Regarding Renal Nutrition
Time Frame: Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
The assessment of attitudes regarding renal nutrition among dietitians will be conducted using a structured questionnaire based on a Likert scale.
This approach allows for the quantification of attitudes related to renal diets, which is crucial for evaluating dietitians' perspectives and enhancing their counselling strategies.
The proposed questionnaire will consist of 45 questions categorized into five Likert scale options: 1= Never, 2= Rarely, 3=Sometimes, 4 = Often, 5= Always.
The scoring system for the questionnaire will range from a minimum score of 45 (if all responses are "Never") to a maximum score of 225 (if all responses are "Always").
|
Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
|
Improved in Practice Regarding Renal Nutrition
Time Frame: Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
This section involvoes 45 questions related to nutrition care practices.
Each question has five possible answers: Never, Rarely, Sometimes, Often, and Always.
The response options: Never (1 point), Rarely (2 points), Sometimes (3 points), Often (4 points) and Always (5 points).
The total score can range from a minimum of 45 (if all responses are "Never") to a maximum of 225 (if all responses are "Always").
|
Timepoint 1 = Baseline. Timepoint 2 = After the intervention (one week post intervention). Timepoint 3 = three months follow-up ( 12 weeks)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UPM-PhDSAlattar
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on No Conditions
-
BEIJING YUANBEN INFORMATION CONSULTING CO., LTDCompletedNo Protrusion | No Open Wound | No Severe Allergic Reaction | No Scar | No Tattoo | No Significant Skin DefectChina
-
UPECLIN HC FM Botucatu UnespUnknownAdult | Inclusion Criteria: | No Pregnancy | No Lactation | No MorbidityBrazil
-
Turtle Shell Technologies Pvt. Ltd.Eastside Research AssociatesRecruitingNo Specific Medical Conditions or Disease States | No Specific ConditionsUnited States
-
Wellell Inc. TaiwanRecruitingNo Condition, Healthy Individuals | No Conditions, Aged 20-64Taiwan
-
Sheba Medical CenterTel Aviv UniversityRecruiting
-
University of AberdeenFight for SightCompleted
-
University of ChichesterCompletedno ConditionsUnited Kingdom
-
Vitastiq d.o.o.MEDEDUS, Ljubljana, Slovenia; Adria Lab, Ljubljana, Slovenia; Vizera d.o.o.; Faculty...Completed
-
Zambon SpACompleted
Clinical Trials on Education intervention
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Roswell Park Cancer InstituteCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Malignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationCompleted
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Mayo ClinicTerminated
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedMalignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy